financetom
THC
financetom
/
Healthcare
/
THC
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Tenet Healthcare CorporationTHC
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Tenet Healthcare Corporation operates as a diversified healthcare services company.

The company operates through three segments: Hospital Operations, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services.

In addition, it operates ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals.

Further, the company offers end-to-end and focused-point business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers.

Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Latest News >
Sarepta Therapeutics Poised for 'Significant Launch Inflection' Amid Positive Elevidys Feedback, RBC Says
Sarepta Therapeutics Poised for 'Significant Launch Inflection' Amid Positive Elevidys Feedback, RBC Says
Jul 29, 2024
11:41 AM EDT, 07/29/2024 (MT Newswires) -- Sarepta Therapeutics' ( SRPT ) Elevidys, a gene therapy for the treatment of Duchenne muscular dystrophy, or DMD, has drawn high interest from physicians and patients, RBC Capital Markets said in a report Monday. The investment firm also said concerns around treatment throughput, center capacity, and manufacturing supply seem to be overdone following...
Update: Collective Mining Gains 3.6% as It Reports Latest Assays from the Trap Target in Colombia
Update: Collective Mining Gains 3.6% as It Reports Latest Assays from the Trap Target in Colombia
Jul 29, 2024
11:43 AM EDT, 07/29/2024 (MT Newswires) -- Collective Mining ( CNL ) on Monday reported assays for four holes drilled at the Trap target within the company's Guayabales project in Colombia. Highlights include 40.85 meters at 3.76 grams per tonne (g/t) gold equivalent within 174.45 meters at 1.19 gold equivalent. The company said the Trap target can rapidly evolve through...
Decoding Broadcom's Options Activity: What's the Big Picture?
Decoding Broadcom's Options Activity: What's the Big Picture?
Jul 29, 2024
Financial giants have made a conspicuous bearish move on Broadcom ( AVGO ). Our analysis of options history for Broadcom ( AVGO ) revealed 33 unusual trades. Delving into the details, we found 39% of traders were bullish, while 42% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $666,294, and 24...
Compugen Gets US FDA Approval for Solid Tumor Treatment Study
Compugen Gets US FDA Approval for Solid Tumor Treatment Study
Jul 29, 2024
11:19 AM EDT, 07/29/2024 (MT Newswires) -- Compugen ( CGEN ) said Monday that the US Food and Drug Administration approved the company's investigational new drug application to start a phase 1 trial for COM503 as a potential treatment for patients with solid tumors. The trial will evaluate COM503 as a monotherapy and in combination with Gilead Sciences' ( GILD...
Copyright 2023-2026 - www.financetom.com All Rights Reserved